Elevance Health partners with Adelade in value-based care push

Elevance Health, formerly known as Anthem, has teamed up with primary care physician enablement company Adelade to push the transition to value-based care.

The partnership aims to assist independent primary care physicians transition to value-based care by giving primary care providers in Elevance Health’s network to access Adelade’s suite of technology and local, in-person services. Elevance and Adelade hope to provide independent primary care providers with the enhanced tools, support, and resources they need to make the transition to value-based care.

“Healthcare reimbursement based on outcomes instead of quantity of services has been debated for decades. Too often, primary care providers want to make this transition but struggle,” Bryony Winn, president of health solutions at Elevance Health, said in a statement. “Partnering with Aledade empowers our independent care provider partners with the tools and insights they need to provide higher quality, more affordable care, while succeeding financially.”

Elevance Health is a health insurance company based in Indianapolis that serves more than 118 million people through a diverse portfolio of industry-leading medical, digital, pharmacy, behavioral, clinical, and complex care solutions. The company was previously known as Anthem until June 2022. The name change comes after a failed mega-merger between Anthem and Cigna that led to the health insurers fighting in court over the breakup––and billions in fees. 

Adelade helps independent practices, health centers and clinics deliver better care to their patients and thrive in value-based care through an accountable care organization. The company was founded in 2014.

“After more than a decade, the data has clearly shown that value-based care centered on independent physicians leads to care that is good for patients, good for doctors, and good for society,” said Farzad Mostashari, MD, CEO and co-founder of Aledade. “Elevance Health continues to be a leader in supporting physicians in the shift to value, and this collaborative effort will help improve the lives of their members while strengthening anchors of primary care in communities across the country.”

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.